X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
heparin-coated circuits (6) 6
humans (6) 6
biocompatibility (5) 5
cardiopulmonary bypass (5) 5
engineering, biomedical (5) 5
male (5) 5
ards (4) 4
extracorporeal membrane oxygenation (4) 4
extracorporeal membrane oxygenation - adverse effects (4) 4
adult (3) 3
biomaterials (3) 3
circulation (3) 3
complement activation (3) 3
complications (3) 3
duraflo-ii (3) 3
female (3) 3
follow-up (3) 3
heparin (3) 3
heparin-coated circuit (3) 3
heparin-coated ecmo (3) 3
inflammatory response (3) 3
retrospective studies (3) 3
transplantation (3) 3
animals (2) 2
biocompatible materials (2) 2
biomedical materials (2) 2
cardiac & cardiovascular systems (2) 2
coated materials, biocompatible - chemistry (2) 2
covalently bonded heparin (2) 2
extracorporeal membrane oxygenation - instrumentation (2) 2
infant, newborn (2) 2
materials testing (2) 2
middle aged (2) 2
oxygenators, membrane - adverse effects (2) 2
percutaneous cardiopulmonary support (2) 2
peripheral vascular disease (2) 2
reduced complement (2) 2
surgical implants (2) 2
thrombosis - etiology (2) 2
thrombosis - prevention & control (2) 2
veno-venous ecmo (2) 2
ヘパリン (2) 2
処理 (2) 2
1) avoiding adverse effects of systemic heparinization, 2) decreasing the deletion of platelet counts, 3) minimizing morphological changes of circulating platelets, 4) preventing thrombi formation in the main streams under low-flow state (1) 1
200-220s) during whole procedure. the results of blood gas exchange in both groups were equally sufficient in terms of o_2 transfer and co_2 removal. in group h, the act level was retained within normal range and oozing at wound and hemorrhage in organs did not occurred. while in group c, oozing at wound had been noted in all cases immediate (1) 1
acute disease (1) 1
acute respiratory failure (1) 1
adults (1) 1
aged (1) 1
animal experiment (1) 1
anti- thrombogenicity (1) 1
anti-thrombogenecity (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - pharmacology (1) 1
anticoagulation (1) 1
antikoagulanz (1) 1
antithrombin iii - analysis (1) 1
apheresis (1) 1
article (1) 1
artificial surfaces (1) 1
biocompatible materials - chemistry (1) 1
biological products (1) 1
biomaterial (1) 1
biomembrane mimicry (1) 1
blood (1) 1
blood coagulation (1) 1
blood coagulation - drug effects (1) 1
blood compatibility (1) 1
blood pumps (1) 1
blood transfusion (1) 1
bypasses (1) 1
cannulation (1) 1
cardiac support (1) 1
cardiopulmonary bypass - adverse effects (1) 1
cardiopulmonary bypass - instrumentation (1) 1
cardiopulmonary bypass - trends (1) 1
cardiopulmonary bypass circuits (1) 1
cardiopulmonary support (1) 1
cardiovascular system (1) 1
centrifugal blood pump (1) 1
cgmp (1) 1
cgmp/p-vasp pathway (1) 1
chronic-renal-failure (1) 1
circuits (1) 1
clinical-evaluation (1) 1
clotting activation (1) 1
co2 removal (1) 1
coagulation (1) 1
coated materials, biocompatible - adverse effects (1) 1
coating effects (1) 1
computational fluid-dynamics (1) 1
coronary artery bypass (1) 1
cps (1) 1
cultured dermal substitute (1) 1
delayed response (1) 1
delayed-action preparations (1) 1
denervated muscle-fibers (1) 1
dental support (1) 1
design engineering (1) 1
dysfunction (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


日本小児外科学会雑誌, ISSN 0288-609X, 1997, Volume 33, Issue 4, pp. 697 - 704
体外式模型人工肺 (ECMO) の施行上,抗凝固療法に伴う出血傾向は大きな問題点である. 我々は出血傾向の克服のため,ヘパリン処理された人工肺及び回路を用いて,抗凝固剤を使用しない ECMO 装置の有用性を低流量域 (50ml/kg/min) での比較実験を行い検討した. 方法 :... 
ヘパリン処理 ECMO 回路 | 先天性横隔膜ヘルニア | 体外式模型人工肺 (ECMO)
Journal Article
European Journal of Cardio-Thoracic Surgery, ISSN 1010-7940, 1995, Volume 9, Issue 4, pp. 226 - 229
Hemorrhagic disorders due to systemic heparinization are frequent duringextracorporeal lung support (veno-venous extracorporeal membraneoxygenation: vv-ECMO).... 
Acute respiratory failure | Heparin-coated system | Extracorporeal membrane oxygenation (ECMO) | Heparinization | EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) | HEPARIN-COATED SYSTEM | HEPARINIZATION | ACUTE RESPIRATORY FAILURE | CARDIOVASCULAR SYSTEM
Journal Article
Scandinavian Cardiovascular Journal, ISSN 0036-5580, 1991, Volume 25, Issue 3, pp. 199 - 206
Journal Article
人工臓器, ISSN 0300-0818, 1996, Volume 25, Issue 4, pp. 829 - 833
We report clinical experiences with using heparin-coated PCPS system consisted of 4.8m2 hollow fiber membrane oxygenator, a centrifugal pump, and percutaneous... 
percutaneous cardiopulmonary support (PCPS) | covalently bonded heparin | heparin-coated circuit | anti-thrombogenecity | extracorporeal membrane oxygenation (ECMO)
Journal Article
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, ISSN 0036-5580, 1991, Volume 25, Issue 3, pp. 199 - 206
Three patients with adult respiratory distress syndrome were treated with veno-venous extracorporeal membrane oxygenation, ECMO, using a heparin-coated system... 
SURGERY | LUNG | CARDIAC & CARDIOVASCULAR SYSTEMS | FOLLOW-UP | VENOVENOUS ECMO | PRIMARY PULMONARY-HYPERTENSION | FAILURE | INTRAVENOUS EPOPROSTENOL PROSTACYCLIN | HEPARIN-COATED ECMO | CO2 REMOVAL | COMPLICATIONS | POSITIVE-PRESSURE VENTILATION | ARDS
Journal Article
Book Review
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.